MEDICEL : where we go ? Mediterranean Network for Coeliac Disease Bologna, April 5 th 2011 ELFID- NAPLES- ITALY.

Slides:



Advertisements
Similar presentations
Diagnostic tools and technology transfer
Advertisements

Cellular Networks.
Sunken Millions for People in our Past Kim McCoig Grade 5 Kim McCoig Grade 5.
Pneumonia: Past and Present
The prospective study and the new ESPGHAN protocol L. Greco, D. Mičetić-Turk Mediterranean Network for Celiac Disease Istanbul, June 30th 2012.
WORKSHOP MEDI-CEL The Mediterranean Network for Celiac Disease Bologna April 2010.
Situation and future developments MEDICEL Meeting MALTA
Prof. Dr. Giuseppe Magazzu Prof. Dr. Dušanka Mičetić-Turk and all Progress of the Prospective study - Medicel.
“Working with the web-database and Biobanking” MEDICEL meeting 2011 Bologna. April Jose Ramon Bilbao.
POINT-OF-CARE TEST FOR DIAGNOSIS OF CELIAC DISEASE Workshop MEDICEL The Mediterranean Network for Celiac Disease III Progress Meeting PastaTrend, BolognaFiere.
The near future, applications and activities G. Magazzù and L. Greco.
FIRST DRAFT OF THE RETROSPECTIVE STUDY Workshop MEDICEL The Mediterranean Network for Celiac Disease III Progress Meeting PastaTrend, BolognaFiere Bologna,
Coeliac disease in Croatia Zrinjka Mišak Sanja Kolaček Referral Center for Paediatric Gastroenterology and Nutrition Children’s Hospital Zagreb, Croatia.
UNIVERSITY CLINICAL CENTER TUZLA DEPARTMENT OF PEDIATRICS BOSNIA AND HERZEGOVINA Dr. SELMA TERZIĆ.
PreventCD Zrinjka Mišak Referral Centre for Paediatric Gastroenteorology and Nutrition Children’s Hospital Zagreb, Croatia.
‘National Pictures of Celiac Disease ‘ GREECE Roma Eleftheria Professor of Paediatric Gastroenterology University of Athens Naples, September 2010.
Italy’s High-Speed Train. Italy launched Europe's first private high-speed train service this week.The dark-red bullet-shaped "Italo" trains are run by.
The Mediterranean Network for the management of food induced diseases WORKSHOP MEDI-CEL The Mediterranean Network for Celiac Disease V Progress Meeting.
4.02R Foods I “MOST WANTED” 4.02R Foods I Most Wanted.
MEDICEL meeting Istanbul 30/06/2012. Objectives and role of AOECS The objective is to disseminate the results of the project as well as finding potential.
Impact of the new ESPGHAN diagnostic criteria for celiac disease in the Mediterranean area The Mediterranean Network for Celiac Disease V Progress Meeting.
April 2005 How Patients Can Benefit From Molecular Imaging Paula M. Jacobs, Ph.D Vice President Advanced Magnetics, Inc.
European Laboratory for Food Induced Diseases (ELFID) University of Naples Federico II University of Naples Federico II Prof. Luigi Greco.
Prof. Dr. Giuseppe Magazzu Prof. Dr. Dušanka Mičetić-Turk and all Progress of the Prospective study - Medicel.
Coeliac disease in Croatia Zrinjka Mišak Referral Center for Paediatric Gastroenterology and Nutrition Children’s Hospital Zagreb.
Italy — mountainous country. area italy – km 2( LiKe the boots ) population – 58.2 million people official language – Ialiant Capital of Italy -
The First MEDICEL Meeting Cairo 30 th April to 1 st May 30 th April to 1 st May Prof. Luigi Greco Dr. Laura Timpone Following ESPGHAN PROTOCOL REVISION.
How to really implement a control quality ? Virtut Velmishi « Mother Teresa Hospital » Tirana-Albania 1 SERVICE OF PEDIATRIC GASTROHEPATOLOGY.
European Laboratory for Food Induced Diseases (ELFID) University of Naples Federico II University of Naples Federico II Prof. Luigi Greco.
Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.
"Marine Protected Areas: a flipped lesson" Isabella Palomba.
MOUNT VESUVIUS Last eruption: 1499 Location: Province of Naples in Italy.
$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.
Celiac Disease: Advances in Treatment via Gluten Modification
ADVERSE EVENTS SURVIELLENE SYSTEM
University of Bologna Bologna (Italy)
Volume 354, Issue 9180, Pages (August 1999)
Research topic: Psychological Adaptation to Coeliac Disease
Rapid streptococcal testing for sore throat and antibiotic resistance
تحليل الحساسية Sensitive Analysis.
الوسائل التعليمية الجمعة 14 آذار 2014 إعداد : هيثم شعيب.
Gut bacterial microbiota and obesity
The prospective study and the new ESPGHAN protocol
بعض النقاط التي تؤخذ في الحسبان عند تقييم الاستثمارات الزراعية
Celiac Disease: Advances in Treatment via Gluten Modification
The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity  M. Fernandez-Feo, G. Wei,
MEDICEL meeting Istanbul 30/06/2012.
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Spreading and focusing of gluten epitopes in celiac disease
Lotta Nylund, Katri Kaukinen, Katri Lindfors 
Coeliac disease The Lancet
Rapid streptococcal testing for sore throat and antibiotic resistance
Dietary Needs.
Percent of adults ages 19– In the past 12 months:
Abstracts from Around the World
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Volume 73, Issue 7, Pages (April 2008)
Regular Physics Chapter 29
Clinical Microbiology and Infection
Summary of trial identification and selection
SERVICE OF PEDIATRIC GASTROHEPATOLOGY
Figure 2 Quality stages by disorder The x-axis lists each of the quality improvement and practice-based research projects in order of implementation at.
Calculus W 11 April 2012.
Joanne was unsure if a surgery she needed was covered under her plan
Editorial Board Orthopedic Clinics Volume 47, Issue 2, (April 2016)
Calculus W 18 April 2012.
The Number of Adults Reporting Not Getting Needed Care Because of Cost Declined in 2014 for the First Time Since 2003 Percent of adults ages 19–
Volume 50, Issue 2, Pages iii-iv (April 2019)
SW HFMA conference 27th September 2019
Presentation transcript:

MEDICEL : where we go ? Mediterranean Network for Coeliac Disease Bologna, April 5 th 2011 ELFID- NAPLES- ITALY

The Past : < Clinical Clear CD Potential CD Gluten Sensitive

The Present : about 1 Million Clinical Clear CD Potential CDGluten Sensitive

The Future > 5 Millions Potential CD Gluten Sensitive Clinical Clear CD

The Past : < Clinical Clear CD Potential CD Gluten Sensitive

The Present : about 1 Million Clinical Clear CD Potential CDGluten Sensitive

The Future > 5 Millions Potential CD Gluten Sensitive Clinical Clear CD